Two trades to watch: Dax ahead of GFK data, WTI extends selloff
Fiona Cincotta December 22, 2020 5:52 PM
Dax remains under pressure on covid strain fears. Could GFK consumer confidence data send the index lower? US spending bill fails to boost WTI.
Europe experienced its worst session in over a month as fears of the new covid strain hit saw investors take risk off the table.News that US Congress has agreed $900 billion covid rescue package and $1.4 trillion government spending package saw US markets pair losses.
Could weak GFK data send the Dax through 13040?
• Dax futures extending sell off on covid fears
• German GFK expected to decline to -9.5 from -6.7
Learn more about index trading opportunities
US stimulus bill fails to boost WTI
• WTI is extending losses on Tuesday, adding to steep losses from Monday as a new strain of covid in the UK triggered concerns over fuel demand recovery.
• The UK has tightened its lockdown measures and a growing number of countries have closed their borders to UK freight and travelers.
• Congress’ approval of giant US spending bill could offer some support
• Look to API inventory data later in the session.
WTI slid sharply lower in the previous session falling through its steep ascending trendline which dates back to late October.
WTI found support at the 20 sma on the daily chart at around $46.40 rebounding off this level to settle around $1 higher.
WTI is once again trading on the back foot and is looking to test the 20 sma and yesterday’s low of $46.40. A break through here could negate the near term bullish trend opening the door to a deeper sell off towards $44.00.
It would take another leg lower towards 50 sma at $42.50 to negate the medium term bullish outlook.
From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.